23
Views
9
CrossRef citations to date
0
Altmetric
PLENARY LECTURES

Triciribine (TCN), A Novel Tricyclic Adenosine Analog with Anticancer Activity

, , , , , & show all
Pages 95-109 | Published online: 05 Dec 2006
 

Abstract

Triciribine shows promise as an antitumor drug and is currently in clinical trials. In L1210 cells in vitro, triciribine lethality is associated with inhibition of DNA synthesis, a G1(-S) cell progression block and slowing of progression of cells through s phase.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.